4DMedical posts FY26 revenue growth as commercial deployment ramps up
4DMedical reports 21% FY26 revenue growth as CT:VQ gains commercial adoption, global regulatory approvals and major healthcare partnerships.
Market Cap $806.4M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
Filters
[Clear]
- Price Sensitive: Yes
| BGP | BGP - 4th Quarter Sales to 26 January 2025 | PRICE SENSITIVE | 04/02/25 | |
| BGP | BGP Full Year Results Announcement to 28 January 2018 | PRICE SENSITIVE | 12/03/18 | |
| BGP BGP - 4th Quarter Sales to 26 January 2025 | |||
| 04/02/25 | PRICE SENSITIVE | ||
| BGP BGP Full Year Results Announcement to 28 January 2018 | |||
| 12/03/18 | PRICE SENSITIVE | ||